High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
This study aimed to evaluate oral and injectable routes in treatment of hypovitaminosis D in multiple sclerosis (MS) patients. The investigators aimed to assess the efficacy of each method, using the same Mega dose of 600 000 IU D3, in achieving normal serum 25(OH)D level, the durability of the response, the practicality and the possible toxicity.
Epistemonikos ID: 1451ccbd60c80965948bdbbbe64b7ab64c146421
First added on: Mar 31, 2022